UK allergy treatment developer Circassia, backed by several investors, plans on raising a total of £209m in its debut on the London Stock Exchange next week, giving it a market cap of £581m.
IK's exit comes two years after it acquired a majority stake in the company via its IK Small Cap II Fund
Inflexion took a minority stake in IT service UKFast in 2018, increasing this to a majority in 2020
Biotech company will use the funding to advance its lead therapeutic programmes into clinical development
UK-based recruitment software platform Beamery has raised a $138m funding round led by Ontario Teachers' Pension Plan Board (OTPP) via its Teachers' Innovation Platform (TIP).